Hydroxyapatite-TiO2 hybrid coating on Ti implants.

Area of Science:

• Biomaterials Science
• Materials Engineering
• Orthopedic Implants

Background:

• Titanium (Ti) implants are widely used but can face biocompatibility challenges.
• Improving implant osseointegration and cellular response is crucial for clinical success.
• Existing surface modifications may not fully optimize cellular interactions.

Purpose of the Study:

• To develop and characterize a hydroxyapatite (HA)-titania (TiO(2)) hybrid coating for titanium implants.
• To evaluate the biocompatibility and cellular response of the novel hybrid coating.
• To compare the performance of the hybrid coating against pure Ti and simple micro-arc oxidation (MAO) treated Ti.

Main Methods:

• A dense HA layer was pre-deposited on Ti via electron beam evaporation.
• Micro-arc oxidation (MAO) was used to create a TiO(2) layer beneath the HA layer, forming a hybrid coating.
• Osteoblast-like cells were cultured on the hybrid coatings, pure Ti, and MAO-treated Ti.
• Cell proliferation and alkaline phosphatase (ALP) activity were measured.

Main Results:

• The MAO treatment resulted in a porous TiO(2) layer with partial HA dissolution, preserving Ca and P on the surface.
• Osteoblast-like cells exhibited favorable growth and spreading on the HA-TiO(2) hybrid coating.
• Cell proliferation rates were comparable across hybrid, pure Ti, and MAO-treated Ti.
• Significantly higher ALP activity (p < 0.05) was observed on the hybrid coatings compared to controls.

Conclusions:

• The developed HA-TiO(2) hybrid coating effectively improves the biocompatibility of titanium implants.
• The enhanced ALP activity suggests superior cellular response and potential for better osseointegration.
• This hybrid coating represents a promising surface modification for orthopedic applications.